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We report a case of a 40-year-old man aﬀected by the Kearns-Sayre syndrome who underwent an elective laparoscopic
cholecystectomy under general anaesthesia. We describe the management of general anaesthesia in this rare myopathy, with
emphasis on the use of rocuronium as muscle blocking agent. Induction was achieved with propofol and fentanyl, and general
anaesthesia was maintained with fentanyl and sevoﬂurane/N2O/O2 mixture. The anaesthetic plan proved to be safe and eﬀective,
and extubation was achieved in the operating theatre. The postoperative recovery of the patient was satisfactory and uneventful.
1.Introduction
Kearns-Sayre syndrome (KSS) is a rare myopathy caused by
mitochondrial DNA deletions with multisystemic involve-
ment [1]. The syndrome has an estimated incidence of 1
to 3 cases in 100.000 inhabitants [2]. The triad of chronic
progressive external ophthalmoplegia, bilateral pigmentary
retinopathy, and cardiac conduction abnormalities was ﬁrst
described in a case report of two patients in 1958 by
Kearns and Sayre [3]. From a clinical point of view, it is
characterised by onset before 20 years of age, ptosis, and the
above-mentioned triad constituted of progressive external
ophthalmoplegia, pigmentary retinopathy, and cardiac con-
ductiondefects.Insomecases,cerebellardysfunction,ataxia,
cerebrospinal ﬂuid protein levels > 100mg/dL, dysphagia,
deafness, proximal muscle weakness, intestinal disorders,
renal failure, and endocrine abnormalities (hypoparathy-
roidism,diabetes)canalsobepresent[1–4].Thediseasepro-
gresses slowly, with new symptoms appearing and previous
symptoms worsening.
2.CaseReport
A40-year-old,68Kgmanpreviouslydiagnosedtobeaﬀected
by KSS presented for laparoscopic cholecystectomy at our
institution. At a preoperative assessment, the patient was
noted to have a trifascicular (ﬁrst degree atrioventricular,
right and left anterior bundle) block on ECG. Holter ECG
monitoring revealed occasional supraventricular ectopy. On
transthoracic echocardiography, no cardiomyopathy was
noted. The ejection fraction was estimated at 55%, and
mitral valve prolapse causing mild mitral regurgitation was
found. No laboratory test abnormalities were disclosed. No
neurologic impairment was noted at the clinical specialist’s
assessment. Preoperative respiratory function was within
normal limits.
The patient had previously undergone general anaesthe-
sia without complications, but the record of that procedure
was not available. Preoperative examination revealed a Mal-
lampatiscoreof2,nopredictivefactorsofdiﬃcultairwaysor
impaired ventilation were observed.
The anaesthetic plan included transthoracic pacing
(placed before induction), set at 50/min with a captur-
ing threshold at 30mA. After insertion of a 20G fore-
arm intravenous cannula and placement of standard moni-
toring, induction was achieved with fentanyl 100µg, propo-
fol 140mg, and rocuronium 25mg (0.35mg/Kg). Tracheal
intubation was successfully performed after 4min at the
ﬁrst attempt. A balanced general anaesthesia technique was
chosen. Additional fentanyl 100µg was administered during2 Case Reports in Anesthesiology
anaesthesia and hypnosis/anaesthesia was maintained with
sevoﬂurane (maximum 1.6%) and N2O/O2 mixture 60/40.
An episode of sinus bradycardia (heart rate 49/min) was
successfully managed with atropine 1mg. Fluid administra-
tion included normal saline 600mL and acetated ringer’s
solution 100mL. Anaesthesia lasted 55min and the patient
was uneventfully extubated in theatre 60min after induction
with no need for reversal as clinical assessment of the
patient showed complete recovery from muscle relaxation.
Analgesia was provided with paracetamol 1g i.v. single
bolus at the end of surgical procedure, plus continuous
infusion of tramadol 150mg over 24 hours. The patient was
then admitted to the intensive care unit (ICU) for planned
postoperative monitoring. He was discharged from the ICU
onpostoperativeday1pain-freeandfollowinganuneventful
stay. No abnormalities in the routine postoperative blood
tests were observed. Discharge from the hospital was on
postoperative day 5.
3. Discussion
W er e p o r th e r eac a s eo fap a t i e n ta ﬀected by KSS who was
successfully and uneventfully managed with a balanced gen-
eral anaesthesia plan using rocuronium as muscle relaxant.
To our knowledge, this is the ﬁrst reported case of a KSS
patient treated with rocuronium. Mitochondrial diseases are
among the most common genetic diseases. Despite this,
little is known about these diseases and anaesthesia. In
particular, for KSS patients, only a few anecdotal reports are
available [4–6]. However, some general and some speciﬁc
considerations can be made.
Despite a broad spectrum of presentation, all mitochon-
drial diseases have skeletal muscle weakness which can be
exacerbated by general anaesthesia leading to postoperative
respiratory failure [6]. Low dose of volatile agents are thus
warranted [1]. With the use of volatile agents, lactic acidosis
can also result [1]. Such acidosis can be further worsened
by the infusion of lactated ringer’s solution, which is best
avoided. Thus, it seemed appropriate to use a low dose of
muscle relaxant to provide good surgical relaxation and to
keep at the lowest possible value inhaled anaesthesia.
Speciﬁc considerations for KSS patients include [4–
7] the risk of complete heart block. Thus, in the pre-
operative evaluation, a Holter ECG was performed to rule
out major arrhythmic episodes and the planned manage-
mentincludedperioperativetransthoracicpacing.Moreover,
congestive heart failure due to dilated cardiomyopathy [8]
canarisebecauseofthecardiodepressanteﬀectofanaesthesia
and ﬂuid overload. However, a pre-operative evaluation of
cardiac function via echocardiography ruled out cardiomy-
opathy and attention was given to avoid ﬂuid overload.
Respiratory function also deserves special attention. KSS
patients have an increased risk of postoperative respiratory
dysfunction both because of prolonged pharmacological
neuromuscular blockade and of reduced respiratory drive,
which can be further depressed by opioid analgesia [6].
However, adequate analgesia is mandatory in the postop-
erative period. Accordingly, despite a normal preoperative
respiratory function, we planned a postoperative ICU period
ofobservationandmonitoringofcardiorespiratoryandneu-
rologic function.
Although recommended, neuromuscular monitoring is
not always available on daily practice. This is the case at
our institution. It is a limitation of our report; however,
this can have practiced useful consideration for everyday life.
Moreover, sugammadex was not available yet at the time of
this report in Italy.
Finally, the associated risk of malignant hyperthermia
(MH) remains unproven [9]. However, it seems reasonable
to avoid agents that can precipitate MH, in particular,
suxamethonium [10]. Volatile agents are also known to be
precipitant of MH. Propofol, on the other hand, has never
been described as a precipitating agent of MH.
Unusual sensitivity to some induction agents, in partic-
ular, to thiopentone and etomidate, has been described [7].
On the other hand, induction with fentanyl and propofol has
been reported to be a safe technique [1, 5, 11] in mitochon-
drialmyopathies.Althoughtotalintravenousanaesthesiawas
considered for the procedure, an inhalation anaesthesia with
sevoﬂurane and N2O has also been shown to be safe for the
maintenance of general anaesthesia [5, 7, 11–13] in those
diseases.
Accordingly, we decided to use induction with fentanyl
andpropofolandmaintenancethroughbalancedanaesthesia
with sevoﬂurane and N2O. Our case conﬁrms previous
reports of eﬃcacy and safety of such a strategy.
The choice of a muscle relaxant took into consideration
previousreportsandtheneedforashort-intermediateacting
a g e n t .A sf a ra sw ek n o w ,n or e p o r t st od a t eh a v eb e e n
published using rocuronium as the muscle relaxant in KSS.
We decided to use such a muscle-blocking agent at the lowest
dosage (0.35mg/Kg) to facilitate intubation and provide
muscle relaxation for surgery in the view of its short-act-
ing action at such a dosage. Moreover, the expected duration
of the drug could cover for the duration of the planned sur-
gery with the possibility to provide small top-ups if needed.
Atracurium and cisatracurium have similar pharmacody-
namic and pharmacokinetic properties and can be valid
alternatives. The technique proved to be safe and eﬀective in
our case.
In conclusion, we report the ﬁrst case of a KSS patient
successfully and safely treated with rocuronium as paralysing
agent for general anaesthesia. We could also conﬁrm previ-
ous reports regarding the safety of propofol and fentanyl as
inductionagentsandofsevoﬂuraneandN2Oasmaintenance
agentsinacaseofKSSpatientwhounderwentgeneralanaes-
thesia.
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